blog

Communicating Leadership Changes

Written by CAM Bioceramics | Dec 13, 2024 8:30:26 AM

Announcement leadership changes CAM Bioceramics

Introducing our new board member: Caspar Hogeboom

CAM Bioceramics, a leading global manufacturer specializing in innovative calcium phosphate solutions for MedTech and LifeScience applications, is pleased to announce that Caspar Hogeboom, the company’s Chief Executive Officer, will step down from his current role to join the board of directors.

This strategic transition follows the recent acquisition of a majority stake in CAM Bioceramics by SHS Capital. As a member of the board, Caspar will play a pivotal role in guiding the company’s future direction, leveraging his extensive leadership experience to support and accelerate growth initiatives.

Over 9 years, Caspar’s leadership as CEO has been instrumental in positioning CAM Bioceramics as a global leader in its field. The company thanks him for his contributions and looks forward to his continued impact in his new role. This leadership change underscores CAM Bioceramics’ commitment to innovation, excellence, and strategic growth as it enters its next phase of development.

Caspar Hogeboom’s Legacy and Vision for CAM Bioceramics

During his tenure as CEO, Caspar Hogeboom has been an inspiring leader at CAM Bioceramics. His strategic vision has driven the company through significant advancements, including the expansion of our portfolio, the reinforcement of our position as a trusted global partner in calcium phosphate solutions, and the achievement of operational excellence through enhanced robustness and the extension of production capacity.

Caspar's vision has always been to push the boundaries of medical innovation. As he transitions to the board, he will continue to support this vision by advising and collaborating with our leadership team to ensure we remain at the forefront of the industry.

How SHS Capital’s Acquisition Supports Our Growth

Last year's acquisition of a majority stake in CAM Bioceramics by SHS Capital is a strategic move designed to support and accelerate our company's growth. This partnership will provide us with the resources and support needed to expand our capabilities and reach new heights in the MedTech and LifeScience sectors.

Together with SHS Capital, we are well-positioned to enhance our impact, delivering exceptional value to our clients and their patients. This acquisition aligns perfectly with our mission to be a trusted partner in calcium phosphate solutions worldwide.

About CAM Bioceramics

CAM Bioceramics is a contract development and manufacturing organization specializing in orthobiologic calcium phosphate solutions for the orthopedic, dental, additive manufacturing, excipients and aesthetic markets. With over four decades of innovation, CAM Bioceramics provides high-quality calcium phosphate solutions to industry leaders worldwide. Operating from Leiden Bio Science Park, a key European life sciences hub, our team upholds rigorous ISO 13485:2016, ANVISA, Ecovadis standards, ensuring reliable, global service and exceptional quality.

Further information at: https://www.cambioceramics.com